Medical device company Masimo has filed a lawsuit against U.S. Customs and Border Protection over the reactivation of the Apple Watch’s Blood Oxygen feature. The company is now seeking to reinstate the import ban on Apple Watch models that use the feature, claiming that CBP overstepped its authority and violated procedural rules. If you are not familiar, Apple recently released iOS 18.6.1, which included a workaround for Blood Oxygen Monitoring through your iPhone, and it appears that the mechanism did not sit well with Masimo.

Masimo challenges U.S. Customs’ approval of Apple Watch Blood Oxygen workaround, seeking to reinstate the original import ban

The dispute between Apple and Masimo began in December of 2023 when the U.S. International Trade Commission, or ITC, ruled that Apple in

See Full Page